Creation of retinochoroidal anastomosis may help those with CRVO
November 1st 2002Mexico City-Surgical treatment of central retinal vein occlusion (CRVO) by the creation of retinochoroidal anastomosis (RCA) may become an effective therapy for some patients with CRVO, according to Hugo Quiroz-Mercado, MD.
Read More
Benefits of bifocal contact lens may depend on aberrations
September 1st 2002Fort Lauderdale, FL-Researchers at the University of Houston College of Optometry are trying to understand why certain individuals do not gain bifocal vision with a multizone bifocal contact lens. The reason could be dependent on an individual's optical aberrations, noted Joy A. Martin, an OD and PhD student, who spoke during the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
Anti-VEGF therapy holds promise for CNV in AMD
July 1st 2002Fort Lauderdale, FL-Anti-vascular endothelial growth factor (anti-VEGF) therapy is a promising treatment of neovascularization brought on by various ocular diseases, including age-related macular degeneration (AMD), according to Lawrence J. Singerman, MD.
Read More
Intravitreal triamcinolone for AMD appears promising, but more studies needed
July 1st 2002Fort Lauderdale, FL-Intravitreal triamcinolone appears to inhibit the growth of choroidal neovascularization (CNV) and reduce subretinal fluid in the short term, but it needs further evaluation, ac-cording to Mark Gillies, MB, BS, PhD.
Read More
AREDS supports the use of nutritional supplements for AMD
July 1st 2002Fort Lauderdale, FL-Of the nearly 60 million people in the United States over age 55, 8 million are estimated to be at high risk for advanced age-related macular degeneration (AMD), making it an important public health concern. However, nutritional supplements may be helpful to reduce this risk, according to the Age-Related Eye Disease Study (AREDS).
Read More
Modified steroid has 'potential' for treating subfoveal CNV in AMD
July 1st 2002Fort Lauderdale, FL-Anecortave acetate (Alcon), a chemically modified steroid, acts in a unique way to suppress abnormal blood vessel growth in patients with subfoveal choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD).
Read More